528 / 1195
2
Too many Tables and Figures.
3
4
No comments.
5
none
6
There is no consistency in the use of technical terms or referencing data tables in the main text.
Some parts of the manuscript could have been explained better. I can provide examples if requested.
7
As outlined in general comments about the method.
Reviewer #
11. Supporting Data and Information
(General comments and method
optimization/precollaborative/single laboratory validation)
: Does the collaborative
study data support the method as written
1
Yes
2
Yes
3
yes
4
Yes
5
The exclusivity test in the pre-collaborative study has only 24 species in stead of 30 species.
6
Yes, the data from the collaborative work does support the method.
7
Data on method comparison in the Eurofin report was not considered in my analysis as confirmation of
screened negative results were not confirmed.
Reviewer #
12.
Supporting Data and Information
(General comments and method
optimization/precollaborative/single laboratory validation)
: Does the data collected
support the criteria given in the collaborative study protocol?
1
Yes
2
Yes
3
Yes
4
Yes
5
Yes
6
Yes, the data supports the criteria in the protocol.
7
Reviewer #
13.
Are there any concerns regarding the safety of the method
(if necessary, refer to the
review from the Safety Advisor)
?
1
No
2
No
3
No
4
There are no specific cautions about Listeria monocytogenes within the method protocol. Listeria
methods, in particular, should provide direct instructions within the methods about precautions for
the analysts with pregnancy/immunosuppression.
5
no
6
There were references to the VIDAS LPT package insert for safety information.
7
No
4
21 June 2013